Milligram per Kilogram per Dose

Known as: mg/kg/dose, mg/kg/{dose} 
A dose calculation unit expressed in milligram(s) per kilogram per single dose.
National Institutes of Health

Related topics

Related topics

1 relation
Clinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Dichloroacetate reverses the hypoxic adaptation to bevacizumab and enhances its antitumor effects in mouse xenografts
Inhibition of vascular endothelial growth factor increases response rates to chemotherapy and progression-free survival in… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma.
New, effective therapies are needed for pancreatic ductal adenocarcinoma. Ipilimumab can mediate an immunologic tumor regression… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Preoperative CTLA-4 blockade: tolerability and immune monitoring in the setting of a presurgical clinical trial.
PURPOSE Cytotoxic T lymphocyte associated antigen (CTLA-4) blockade is being explored in numerous clinical trials as an immune… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Systemic delivery of neutralizing antibody targeting CCL2 for glioma therapy
Tumor-associated macrophages (TAMs) and myeloid-derived suppressor cells (MDSCs) inhibit anti-tumor immune responses and… (More)
  • figure 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2005
2005
Safety and efficacy of Sildenafil therapy in children with pulmonary hypertension.
OBJECTIVE Sildenafil is a selective Phosphodiesterase-5 inhibitor that has been reported to be a potent pulmonary vasodilator. We… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Inhibition of the vascular endothelial growth factor VEGF-VEGF receptor (VEGF-R) kinase axes in the tumor angiogenic cascade is a… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth.
We investigated the effect of 2-methyl-arachidonyl-2'-fluoro-ethylamide (Met-F-AEA), a stable analog of the endocannabinoid… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1997
1997
Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: a multicenter clinical trial.
OBJECTIVES To study whether early postnatal (<12 hours) dexamethasone therapy reduces the incidence of chronic lung disease in… (More)
  • table 2
  • figure 1
  • table 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Efficacy of systemic administration of irinotecan against neuroblastoma xenografts.
The efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptotheci n (irinotecan… (More)
  • table I
  • figure I
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
1993
Highly Cited
1993
Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against human tumor xenografts: lack of cross-resistance in vivo in tumors…
The efficacy of the topoisomerase I inhibitor CPT-11 [7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxycamptothec in] has… (More)
  • table I
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?